Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pfizer (NY:PFE)

24.94 -0.06 (-0.23%)
Streaming Delayed Price Updated: 10:32 AM EST, Dec 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Pfizer

< Previous 1 2
...
25 26 27 28 29 30 31 32 33
...
39 40 Next >
2022 Primed after 2021’s Record M&A Deals
Via Investor Brand Network
2022 Primed after 2021’s Record M&A Deals
NetworkNewsWire Editorial Coverage New York, NY – March 1, 2022 – Last year was a monumental year for merger and acquisition activity. Records worldwide weren’t just broken, they were smashed by M&A... 
Via FinancialNewsMedia
News headline image
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
From Pfizer Inc.
Via Business Wire
News headline image
mRNA Vaccines in Medical Engineering Cancer Treatment
New York, NY -- (SBWIRE) -- 02/24/2022 -- The same mRNA technology used in Pfizer-BioNTech's and Moderna's Covid vaccines is being trialed as a unique new medical engineering cancer treatment. The way... 
Via SBWire
News headline image
Pfizer Invests $68.5 Million in New Pharma R&D Facility
New York, NY -- (SBWIRE) -- 02/24/2022 -- Gene therapy is a vital field and one generating a wealth of R&D jobs in pharma today. Companies such as Pfizer are keen to capitalize on progress, as this... 
Via SBWire
News headline image
Pfizer Invites Public to View and Listen to Webcast of Pfizer Keynote Presentation at Healthcare Conference
From Pfizer Inc.
Via Business Wire
U C, Inc., SMMR, Appoints New Board Member and CEO
U C, Inc., formerly named Symmetry Technologies, Inc. (OTC: SMMR), (the "Company"), announced today that, effective Feb. 14, 2022, it has appointed David Reckles as a new member to its Board of... 
Via Newswire.com
Topics Stocks
News headline image
Pfizer and OPKO’s Once-Weekly NGENLA™ (somatrogon) Injection Receives Marketing Authorization in European Union for Treatment of Pediatric Growth Hormone Deficiency
From Pfizer Inc.
Via Business Wire
News headline image
European Medicines Agency Approves Pfizer’s 20-Valent Pneumococcal Conjugate Vaccine Against Invasive Pneumococcal Disease and Pneumonia in Adults
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer and BioNTech Provide Update on Rolling Submission for Emergency Use Authorization of Their COVID-19 Vaccine in Children 6 Months Through 4 Years of Age
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer Reports Fourth-Quarter and Full-Year 2021 Results
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer and BioNTech Initiate Rolling Submission for Emergency Use Authorization of Their COVID-19 Vaccine in Children 6 Months Through 4 Years of Age Following Request From U.S. FDA
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer Announces New Chief Development Officer
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer and AWS Working Together to Speed Up Clinical Operations Trials
New York, NY -- (SBWIRE) -- 01/28/2022 -- Technology is vital to optimizing the process of clinical operations trials in the near future - and this has been brought one step closer by the news that... 
Via SBWire
News headline image
European Commission Approves LORVIQUA® (lorlatinib) as a First-Line Treatment for ALK-Positive Advanced Lung Cancer
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer Receives CHMP Positive Opinion for Novel COVID-19 Oral Treatment
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer and BioNTech Initiate Study to Evaluate Omicron-Based COVID-19 Vaccine in Adults 18 to 55 Years of Age
From Pfizer Inc.
Via Business Wire
R&D Spending Increases Exponentially for Higher Standard of Breast Cancer Drug Treatments
Palm Beach, FL – January 27, 2022 – FinancialNewsMedia.com News Commentary – According to International Agency for Research on Cancer (IARC) published by the World Health Organization (WHO) in 2018,... 
Via FinancialNewsMedia
Topics Death Intellectual Property
Dietary Supplements Market Growing at a CAGR of 7.0% | Key Players are Amway, Herbalife Nutrition, ADM, Pfizer, Abbott Laboratories, Bayer, Glanbia, Nature’s Sunshine Products
Via AB Newswire
News headline image
Pfizer and OPKO Provide Update on the Biologics License Application for Somatrogon for Pediatric Growth Hormone Deficiency
From Pfizer Inc.
Via Business Wire
Promising Research in Fight Against Breast Cancer Being Amplified by an Active Biotech Sector
FN Media Group Presents USA News Group News Commentary Vancouver, BC –January 20, 2021 – USA News Group – As the 2021 San Antonio Breast Cancer Symposium (SABCS) comes to a close, many of this year’s... 
Via FinancialNewsMedia
Todos Medical Releases Videos of Recent CEO Interviews with Fox Business, NewsMax and Black News Channel on COVID Testing & Treatment Strategies
New York, NY, and Tel Aviv, ISRAEL - (NewMediaWire) - January 18, 2022 - Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today released videos of... 
Via NewMediaWire
News headline image
U.S. FDA Approves Pfizer’s CIBINQO® (abrocitinib) for Adults with Moderate-to-Severe Atopic Dermatitis
From Pfizer Inc.
Via Business Wire
Breast Cancer Treatment Advancements Emerge After New Study Finds Global Deaths Increased in 2019
FN Media Group Presents USA News Group News Commentary Vancouver, BC – January 14, 2022 – USA News Group – Cancer cases are on the rise, according to a new study comparing the number of cancer... 
Via FinancialNewsMedia
Topics Death
DGE’s Investigator Initiated Trials Summit
Via Investor Brand Network
News headline image
Positive Top-Line Results of Pfizer’s Phase 3 Study Exploring Coadministration of PREVNAR 20™ With Pfizer-BioNTech COVID-19 Vaccine in Older Adults Released
From Pfizer Inc.
Via Business Wire
With Full Enrollment Complete In Its Phase 2 COVID-Related GI Treatment Trial, First Wave Bio Could Earn An EUA Sooner Than Later (NASDAQ: FWBI)
Via AB Newswire
News headline image
Pfizer Enters into Agreement with Acuitas Therapeutics for Lipid Nanoparticle Delivery System for Use in mRNA Vaccines and Therapeutics
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer and Beam Enter Exclusive Multi-Target Research Collaboration to Advance Novel In Vivo Base Editing Programs for a Range of Rare Diseases
From Pfizer Inc.
Via Business Wire
< Previous 1 2
...
25 26 27 28 29 30 31 32 33
...
39 40 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.